247 filings
Page 3 of 13
8-K
a5c289i1dsrptx
14 Apr 21
Lumos Pharma to Host Key Opinion Leader Event on LUM-201 for the Treatment of Pediatric Growth Hormone Deficiency
4:16pm
8-K
qe9atmxq25xn
23 Mar 21
Data show greater GH response in pediatric growth hormone deficiency (PGHD) from LUM-201 than standard GH secretagogues
4:19pm
8-K
g6cbxg1c2
9 Mar 21
Lumos Pharma Reports Full Year 2020 Financial Results and Provides Update on OraGrowtH Trials in PGHD
4:26pm
8-K
j7jy7
4 Mar 21
Other Events
9:09am
8-K
y21 1bj33c598ayx4f
2 Mar 21
Other Events
4:30pm
8-K
klof59o
16 Feb 21
Lumos Pharma Announces Changes to its Board of Directors
12:00am
8-K
jc0 l3zugtt9r0
8 Feb 21
Departure of Directors or Certain Officers
5:05pm
8-K
ni7i8t2me
30 Dec 20
Entry into a Material Definitive Agreement
4:44pm
8-K
ifxmo
21 Dec 20
Other Events
4:34pm
8-K
cvpoywu7 ogw
11 Dec 20
Other Events
4:11pm
8-K
t28ahascw1y9zo6tgw
10 Nov 20
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
4:31pm
8-K
zks5f 9uo70ajasroope
13 Aug 20
Lumos Pharma Reports Second Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:36pm
8-K
kbrfysdews90uw
3 Aug 20
Submission of Matters to a Vote of Security Holders
4:58pm
8-K
3azs8lq oq2k
27 Jul 20
Lumos Pharma Announces Sale of Priority Review Voucher
4:31pm
8-K
mbj71cc tvq3faw5ij
9 Jun 20
Other Events
5:07pm
8-K/A
h1qai42 ev5hikv4ze6m
1 Jun 20
Other Events
12:00am
8-K
5zbghs4zzbrlk4gq95e
28 May 20
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
4:41pm
8-K
2v68gq dde
14 May 20
Other Events
4:16pm
8-K
28bl5 466
24 Apr 20
Other Events
10:04am
8-K
f00w bcbvicg1rqjr1gl
2 Apr 20
Departure of Directors or Certain Officers
4:32pm